Cargando…
Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809271/ https://www.ncbi.nlm.nih.gov/pubmed/36605186 http://dx.doi.org/10.3389/fimmu.2022.1119363 |
| _version_ | 1784863085543030784 |
|---|---|
| author | Martin, Francisco Schambach, Axel Maccalli, Cristina |
| author_facet | Martin, Francisco Schambach, Axel Maccalli, Cristina |
| author_sort | Martin, Francisco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9809271 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98092712023-01-04 Editorial: Engineered immune cells in cancer immunotherapy (EICCI) Martin, Francisco Schambach, Axel Maccalli, Cristina Front Immunol Immunology Frontiers Media S.A. 2022-12-20 /pmc/articles/PMC9809271/ /pubmed/36605186 http://dx.doi.org/10.3389/fimmu.2022.1119363 Text en Copyright © 2022 Martin, Schambach and Maccalli https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Martin, Francisco Schambach, Axel Maccalli, Cristina Editorial: Engineered immune cells in cancer immunotherapy (EICCI) |
| title | Editorial: Engineered immune cells in cancer immunotherapy (EICCI) |
| title_full | Editorial: Engineered immune cells in cancer immunotherapy (EICCI) |
| title_fullStr | Editorial: Engineered immune cells in cancer immunotherapy (EICCI) |
| title_full_unstemmed | Editorial: Engineered immune cells in cancer immunotherapy (EICCI) |
| title_short | Editorial: Engineered immune cells in cancer immunotherapy (EICCI) |
| title_sort | editorial: engineered immune cells in cancer immunotherapy (eicci) |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809271/ https://www.ncbi.nlm.nih.gov/pubmed/36605186 http://dx.doi.org/10.3389/fimmu.2022.1119363 |
| work_keys_str_mv | AT martinfrancisco editorialengineeredimmunecellsincancerimmunotherapyeicci AT schambachaxel editorialengineeredimmunecellsincancerimmunotherapyeicci AT maccallicristina editorialengineeredimmunecellsincancerimmunotherapyeicci |